# Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

> **NCT01763606** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 20 (actual)

## Conditions studied

- Cancer Patients First-ever Acute Ischemic Stroke

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT01763606
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-18
- **Primary completion:** 2019-04-03
- **Final completion:** 2019-04-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01763606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01763606, "Enoxaparin Versus Aspirin in Patients With Cancer and Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01763606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*